Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer
NCT00276276
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class
Conditions
Lung Cancer, Small Cell
Interventions
DRUG:
topotecan
Sponsor
GlaxoSmithKline